Nia Health GmbH specializes in innovative medical technology based on a MedTech platform for personalized patient support through medical software. Their end-to-end solutions focus on personalized and indication-specific care, primarily in dermatology and allergology. Their Digital Therapeutics (DTx) combine clinical validation with empowerment, gamification, and machine learning to provide a personalized patient experience aimed at removing barriers to health behavior change.

Nia Health offers various solutions including Digital Therapeutics development, Remote Patient Monitoring, and Digital Trial Tools. Notable patient apps include the award-winning Eczema app Nia, the Psoriasis app Sorea, and the soon-to-be-released Acne app Milderma, all approved as medical devices and designed to support patients with chronic skin conditions through innovative digital health solutions.

Nia Health's products are CE approved medical devices, supported by clinical efficacy studies. The company prioritizes data security and GDPR compliance, with ISO 27001 certification ensuring strict confidentiality of patient data.

The company collaborates with leading dermatologists and clinicians worldwide and has won awards such as the Deep Tech Award 2022 in the Artificial Intelligence category. They work closely with health insurance companies for reimbursement and are member of various industry initiatives.